A reversible albumin-binding once-weekly growth hormone (GH) treatment (somapacitan; NNC0195-0092) induces a dose-dependent IGF-I response similar to daily GH therapy in children with growth hormone deficiency (GHD)

Tadej Battelino

講演情報

APPES/JSPE ジョイントセッション（英語）

APPES/JSPE ジョイントセッション（英語） » Oral

Oral 4: Growth

2016年11月19日(土) 10:45 〜 11:45 第1会場 (Hall C)

Moderator: Junko Ito (The Head of Department of Pediatrics, Toranomon Hospital Tokyo), Melinda Atienza (Department of Pediatrics Faculty of Medicine and Surgery University of Santo Tomas Manila)

10:45 〜 10:55

[O4-1] A reversible albumin-binding once-weekly growth hormone (GH) treatment (somapacitan; NNC0195-0092) induces a dose-dependent IGF-I response similar to daily GH therapy in children with growth hormone deficiency (GHD)

Tadej Battelino¹, ^○Michael Højby Rasmussen², Jean de Schepper³, Nehama Zuckerman-Levin⁴, Zoran Gucev⁵, Lars Sävendahl⁶ (1.Faculty of Medicine, University of Ljubljana, 2.Global Development, Novo Nordisk A/S, 3.Division of Paediatric Endocrinology, Universitair Ziekenhuis Brussel, 4.Pediatric and Obesity Clinic, Rambam Medical Center, 5.University Paediatrics Clinic, Medical Faculty Skopje, 6.Department of Women’s and Children’s Health, Karolinska Universitetssjukhuset)

抄録パスワード認証
抄録の閲覧にはパスワードが必要です。パスワードはプログラム抄録集に掲載しております。